ArticleCurrent oncology (Toronto, Ont.)2020

Real World First-Line Treatments and Outcomes of Nab-Paclitaxel Plus Gemcitabine, mFOLFIRINOX and GEMOX in Unresectable Pancreatic Cancer from a Chinese Single Institution.

Qi Quan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.